These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3810539)

  • 1. [Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. In vitro and in vivo study].
    Doutremepuich C; Bonini F; de Seze O; Toulemonde F; Bayrou B
    Therapie; 1986; 41(6):433-6. PubMed ID: 3810539
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimal functional sequence of protamine.
    Liang JF; Yang VC; Vaynshteyn Y
    Biochem Biophys Res Commun; 2005 Oct; 336(2):653-9. PubMed ID: 16139792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
    Doutremépuich C; Bonini F; Toulemonde F; Bertrand H; Bayrou B; Quilichini R
    Semin Thromb Hemost; 1985 Jul; 11(3):318-22. PubMed ID: 4048954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 8. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body response to a second dose of heparin after heparin neutralization by protamine.
    Belko JS; Lerman SF
    J Cardiovasc Surg (Torino); 1966; 7(3):219-21. PubMed ID: 5938808
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative neutralization of lung- and mucosal-derived heparin by protamine sulfate using in vitro and in vivo methods.
    Lowary LR; Smith FA; Coyne E; Dunham NW
    J Pharm Sci; 1971 Apr; 60(4):638-40. PubMed ID: 5128383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 17. Protamine sulfate neutralization of lactobionic acid amides.
    Hoppensteadt D; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 2():153-7. PubMed ID: 1948086
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin, protamine, and ionized calcium in vitro and in vivo.
    Goto H; Kushihashi T; Benson KT; Kato H; Fox DK; Arakawa K
    Anesth Analg; 1985 Nov; 64(11):1081-4. PubMed ID: 3931505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.